Company news

Orthocell Ltd news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

CelGro Nerve Regeneration Results in Quadriplegic Patients

October 8, 2019

Successful CelGro Tendon Regeneration Trial

September 3, 2019

CelGro Study Validates High Quality Nerve Repair

July 25, 2019

CelGro Accelerates Dental Implant Treatments

June 18, 2019

Orthocell announces successful capital raising

May 30, 2019

First Patients Complete Nerve Regeneration Trial

May 7, 2019

Orthocell Submits AUS Regulatory Application for CelGro

April 30, 2019

Orthocells Ortho-ATI shows 82% success rate

February 12, 2019

CelGro Approved in Key UK Public Dental Hospital

December 10, 2018

Share Placement Successfully Raises $1.8m

December 10, 2018

Patient Treatment Completed in Dental Implant Study

November 28, 2018

OCC Receives New Patents for Celgro Platform Technology

November 1, 2018

Investor Update

October 30, 2018

Orthocell Secures CelGro Patent Protection in Japan

October 22, 2018

Successful CelGro Results Presented at Key Euro Conference

October 17, 2018

Orthocell Receives A$2.5m R&D tax Incentive Refund

October 10, 2018

CelGro Used as Artificial Periosteum Repairs Bone

October 3, 2018

CelGro used in Nano Medicine Breakthrough

September 27, 2018

Preliminary Final Report and Annual Financial Statements

August 31, 2018

OCC Reports First Product Use and Sales of CelGro in Ireland

July 26, 2018

CelGro Pre-Submission Meeting Completed with the FDA

July 24, 2018

Orthocell Receives New Patent for Celgro Platform Technology

July 20, 2018

OCC Reports First Product Use and Sales of Celgro in Italy

July 18, 2018

Orthocell Appoints Exclusive Distributor in the UK

July 9, 2018

New CelGro Arthroscopic Tendon Regeneration Study Commences

July 1, 2018

Orthocell Announces Successful Ortho-ATI Study Results

June 13, 2018

Orthocell Announces Successful Tendon Study Results

June 6, 2018

First Product Use and Sales of CelGro in Poland

May 30, 2018

Orthocell Secures CelGro Patent Protection in Europe

May 24, 2018

First Product Use and Sale of CelGro in Europe

May 21, 2018

10th Patient Treatment Milestone in Human Tendon Study

May 17, 2018

Orthocell Extends Distributor Network in the EU

May 7, 2018

Orthocell Announces Successful Bone Repair Study Results

April 30, 2018

Orthocell Appoints First Distributor in the EU

April 29, 2018

New Cell Factory Patent Granted in the US

February 21, 2018

Positive CelGro Study Results in ACL Reconstruction

February 4, 2018

Appendix 4C - quarterly

January 31, 2018

Orthocell Granted Canadian Tendon Regeneration Patent

January 30, 2018

New Patent for Suture-Less Repair of Soft Tissue Secured

January 17, 2018

50% Patient Treatment Milestone in Human Nerve Trial

January 1, 2018

Orthocell Granted European Tendon Regeneration Patent

December 14, 2017

Ortho-ATI Case Study Publication

December 7, 2017

Orthocell Commences Treatment of Its 1,000th Patient

December 6, 2017

Orthocell Granted European Cartilage Regeneration Patent

November 30, 2017

Orthocell Receives CE Mark for CelGro

November 8, 2017

Orthocell receives R&D tax incentive refund

October 23, 2017

Orthocell Granted CelGro Patent Protection in Canada

October 15, 2017

Notice of Annual General Meeting/Proxy Form

October 13, 2017

Surgical Specialties Appointed as Exclusive Distributor

October 10, 2017

Celgro Positive Safety and Performance in Human Hip Study

September 5, 2017

← Newer news releases · Older news releases →

Decks

The 5 newest of 35 decks. Every deck is listed under its year.